News

GET IN TOUCH

LATEST NEWS

INSIGHTS AND ADVICE FROM OUR TEAM

Home > News > INDUSTRY NEWS >

27 May 2024

Tackling Manufacturing Failures for Viral Vectors

A company founded last year is hoping to tackle a major problem in gene therapy—the failure of therapies to reach the marketplace due to production failures.
Find out more
10 Apr 2024

Generic lomustine to be first product of US-based partnership

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to produce lomustine, which is used to treat brain tumors.
Find out more
20 Mar 2024

Novo Invests $556M in China Operations to Boost Manufacturing Capacity

Novo Nordisk is investing approximately $556 million, or ¥4 billion, in a sterile preparations expansion project in its facility in China’s Tianjin city, the Danish drugmaker announced Tuesday in a Chinese-language announcement.
Find out more
27 Feb 2024

Alcami Grows Drug Testing Footprint In Wilmington

North Carolina pharmaceutical company Alcami Corporation has doubled its stability storage capability in Wilmington.
Find out more
31 Jan 2024

AbbVie pumps $223M into Singapore biologics plant, plots 100 hires

In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. Now, a little more than a year later, AbbVie is getting in on the action by starting a major production expansion in the Ga
Find out more
15 Jan 2024

Boehringer Ingelheim Expands Facility in Greece for Production of New Therapeutics

On Jan. 11, 2024, Boehringer Ingelheim announced that it is investing €120 million (US$131 million) to further expand and upgrade its production facility in Koropi, Greece. With the investment, the company plans to increase manufacturing capacity of new a
Find out more
09 Jan 2024

WuXi Biologics plans to expand manufacturing capacity at The Reactory

A Chinese pharmaceutical firm that is looking to make The Reactory life sciences park off Belmont Street its home will expand its drug manufacturing capacity by 50%, according to the company.
Find out more
25 Dec 2023

CDMO expands ADC facility in Scotland

Contract development and manufacturing organisation, Piramal Pharma Solutions, has expanded its antibody drug conjugate manufacturing facility in Scotland.
Find out more
18 Dec 2023

WuXi Vaccines Clears First GMP Audit

WuXi Vaccines, a global vaccine CDMO, has successfully passed an on-site GMP audit by a global vaccine company at its first standalone CDMO site in Suzhou, China.
Find out more

WANT TO KNOW MORE ABOUT HOW OUR

SOLUTIONS CAN HELP YOU?

GET IN TOUCH

Our site uses cookies. We’d also like to set optional cookies to give you the best experience and porvide you relevant advertising. You can choose to manage your preferences or accept all cookies. You can also read our Privacy Policy and Cookie Policy for more information.